U.S. Infrastructure Stock News

Universal Display (OLED) drew fresh investor attention after unveiling OLEDX, a device architecture aimed at improving light extraction in OLED panels while remaining compatible with existing production lines across smartphone and advanced display applications. See our latest analysis for Universal Display. The OLEDX announcement has arrived during a mixed period for Universal Display, with a 1-day share price return of 2.47% to US$86.54, a 30-day share price return of 6.13%, a year-to-date...

Badger Meter, Inc.’s Board of Directors previously approved a 10% increase in its quarterly common stock dividend to US$0.44 per share from US$0.40, payable on September 11, 2026, to shareholders of record on August 28, 2026, lifting the annual dividend rate to US$1.76 per share. This higher payout underscores management’s confidence in Badger Meter’s cash generation and reinforces its emphasis on returning capital to shareholders alongside its growth investments. We’ll now explore how this...

Datavault AI Inc. recently reported second-quarter 2026 results showing revenue rising to US$6.72 million from US$1.74 million a year earlier, alongside a much larger net loss of US$88.03 million and an impairment charge, while also filing a US$3.47 million shelf registration and announcing delays to its next 10-Q filing. These earnings arrived as Datavault AI faced securities class action lawsuits over alleged past misstatements and signed a wide-ranging real-world asset tokenization...

The OpenAI training pause and the real world hack it uncovered have turned AI safety from a niche concern into front page risk. For investors, that shines a spotlight on software providers that help large organisations prove they are in control of powerful systems and data. This article explores 3 stocks from an AI governance, risk and compliance screener that appear closely tied to this surge in attention. The three stocks that follow are a starting sample from this theme. The full screen...

Spyre Therapeutics stock reacts to new SPY772 program and SKYLIGHT trial launch Spyre Therapeutics (SYRE) is in focus after the company launched its SPY772 combination program and began SKYLIGHT, a Phase 2 proof of concept trial in Hidradenitis Suppurativa. Both efforts target dual inhibition of TL1A and IL-17A/F in moderate to severe HS. The approach uses SPY072 alongside background bimekizumab therapy for around 150 adult participants. See our latest analysis for Spyre Therapeutics. Spyre...

Index removals put Liberty Broadband in focus Liberty Broadband (LBRD.K) has recently been removed from both the S&P Global BMI Index and the S&P TMI Index. This has prompted fresh attention on how index driven flows might influence the stock. See our latest analysis for Liberty Broadband. The recent index removals have come after a volatile period for Liberty Broadband, with a 30 day share price return of 18.64% and a year to date share price return that is down 26.10%. Over the same period,...

Diodes (DIOD) has moved into focus after a series of financing steps, including an amendment to its senior credit facilities and a US$325 million zero coupon convertible note offering that runs through 2031. See our latest analysis for Diodes. These financing moves come after a sharp share price pullback in the last week, with a 7 day share price return down 11.88%. Diodes still shows an 83.39% year to date share price return and a 79.28% 1 year total shareholder return, suggesting momentum...

WhiteFiber (WYFI) is drawing fresh attention after agreeing to serve as Krambu's exclusive GPU infrastructure operator for 100MW of planned high density data center capacity, creating a clearly defined AI focused pipeline for 2027. See our latest analysis for WhiteFiber. WhiteFiber shares have pulled back sharply in the short term, with the 1 day share price return down 21.02% and the 7 day share price return down 25.19%. However, the year to date share price return of 27.04% and 1 year total...

HA Sustainable Infrastructure Capital, Inc. recently reported higher second-quarter 2026 revenue of US$120.79 million and net income of US$128.63 million, affirmed a quarterly cash dividend of US$0.425 per share payable in October 2026, and disclosed materially lower net income for the first half of 2026 versus a year earlier. The company also closed its first water infrastructure structured equity investment in Washington State’s Pasco Resource Recovery Center, backed by a 30-year...

Labcorp Holdings (LH) is in focus after announcing a new alliance with the National Association of Community Health Centers. The partnership centers on leadership development and practice improvement across the Community Health Center network. See our latest analysis for Labcorp Holdings. Alongside this new community health partnership, Labcorp Holdings has seen building momentum in its stock, with a 30 day share price return of 17.39% and a 1 year total shareholder return of 20.08%,...

With Fed minutes hinting at possible rate hikes and no clear path to cuts, short-duration cash and money-market products are back in the spotlight. Investors are paying closer attention to where their idle cash sits and who might benefit if yields stay higher for longer. This article walks through three stocks linked to these cash and liquidity themes that appear especially exposed to the latest policy and inflation signals. The stocks covered below are only a starter sample. The full screen...

ExlService Holdings (EXLS) has secured a new US$1b senior secured credit facility that expands its borrowing capacity and relaxes certain covenants. This refinancing supports potential acquisitions and ongoing share repurchases within its AI focused growth plan. See our latest analysis for ExlService Holdings. The refinancing headlines arrive after a sharp swing in ExlService Holdings' share price, with a 1 month share price return of 31.35% and a 3 month share price return of 26.65%. Even...

GameStop stock has delivered a steep decline of about 63.5% over the past five years, yet on current checks it screens as undervalued on traditional market multiples and only a mixed value story overall. That split leaves investors weighing a weak long term share price record against valuation metrics that do not clearly flag the stock as either a bargain or obviously expensive. Over the past five years, GameStop has declined about 63.5%, which means long term shareholders have absorbed...

Chime Financial (CHYM) has drawn increased attention after recent share price moves, with the stock’s gain of 51% over the past month and 83% over the past 3 months prompting closer investor scrutiny. See our latest analysis for Chime Financial. The strong recent momentum in Chime Financial’s share price, including a 50.8% 1 month share price return and 82.5% 3 month share price return, contrasts with a more moderate 24.5% 1 year total shareholder return. This difference may indicate shifting...

Edgewise Therapeutics, Inc. reported second-quarter 2026 results showing a net loss of US$57.33 million and basic loss per share of US$0.53, with first-half 2026 net loss reaching US$106.34 million and loss per share of US$0.99, both higher than the same periods a year earlier. The widening losses highlight the company’s increasing spending relative to its current revenue base, which will be central to assessing its financial trajectory and funding needs. Next, we will examine how the...

IDEXX Laboratories has launched the Catalyst proBNP Test, the first dual-species in-clinic NT-proBNP cardiac assay for cats and dogs, extending its connected diagnostics portfolio and enabling real-time cardiac assessment on its nearly 80,000-strong Catalyst analyzer base. By opening access to an estimated US$4.00 billion global cardiac testing opportunity and embedding decision support into VetConnect PLUS, the new test could deepen IDEXX’s role in everyday veterinary cardiac care...

Recent share price context for Lakeland Financial Lakeland Financial (LKFN) has drawn investor attention after recent share price moves, with the stock closing at US$60.07 on 18 August 2026. Short term returns have been mixed over the past week and month. See our latest analysis for Lakeland Financial. The recent pullback in Lakeland Financial's 1 day share price return of 2.29% and 7 day share price return of 3.5% contrasts with a positive year to date share price return of 6.39% and a 3...

Lyntris (LYNX) has just completed a US$297.5 million IPO, offering 17,000,000 common shares at US$17.50 each in a sponsor backed deal. That pricing now anchors its early trading. See our latest analysis for Lyntris. Since listing at US$17.50, Lyntris has seen its share price fall 14.23% on a 1 day basis to US$15.01, signalling fading early momentum as investors reassess the sponsor backed IPO valuation. If the Lyntris IPO has you thinking about other potential opportunities in defense related...

In mid-August 2026, Gates Industrial Corporation saw its shares react to weaker-than-expected July U.S. industrial production data reported by the Federal Reserve, which raised concerns about softer activity across key manufacturing end markets. This macro-driven shift highlights how sensitive Gates Industrial’s outlook can be to changes in broad U.S. industrial output rather than only company-specific news. We’ll now examine how worries about slower U.S. industrial production might...

Over the past six months, Vita Coco Company has delivered strong quarterly results and robust volume gains, with average quarterly volume up 15.2% over the last two years compared with peers. This consistently faster volume expansion versus competitors highlights Vita Coco’s growing brand strength and operational momentum in the coconut water category. We’ll now explore how Vita Coco’s outsized volume growth and recent performance may influence its existing investment narrative and risk...

Cullinan Therapeutics (CGEM) is back in focus after announcing that the global Phase 3 REZILIENT3 trial of zipalertinib plus platinum chemotherapy in EGFR exon 20 insertion non small cell lung cancer met its primary endpoint. See our latest analysis for Cullinan Therapeutics. The Phase 3 REZILIENT3 update arrives after a strong run in Cullinan Therapeutics' stock, with a 1 month share price return of 28.69% and a year to date share price return of 122.53%. Over a longer horizon, the 1 year...

QuinStreet’s latest earnings and guidance draw investor focus QuinStreet (QNST) has moved into the spotlight after reporting quarterly and full year results that showed higher sales and net income, alongside new revenue guidance for fiscal 2027 that signals management confidence. See our latest analysis for QuinStreet. QuinStreet’s recent earnings announcement and acquisition commentary have been met with strong momentum, with a 30 day share price return of 23.01% and a 3 year total...

Taysha Gene Therapies recently reported second-quarter 2026 results showing a net loss of US$46.64 million and basic loss per share of US$0.13, while also completing patient dosing in pivotal TSHA-102 Rett syndrome trials that achieved a 100% responder rate in Part A by 12 months. Alongside this clinical progress, the company expanded its commercial manufacturing partnership with Catalent and secured US$230 million in financing, extending its cash runway into late 2028 and reinforcing its...

Earlier this month, Camden Property Trust filed an $802.865 million shelf registration to offer 7,250,000 common shares of beneficial interest for an ESOP-related program. This sizable ESOP-linked shelf suggests Camden is preparing to use equity more actively in employee ownership and compensation, with potential implications for its capital structure. We’ll now explore how this large ESOP-related equity shelf may affect Camden’s existing investment narrative built around Sun Belt...